MedTech Startup Axio Biosolutions Raises $6 Million in Series B2 Funding
Axio Biosolutions, a MedTech company, announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from ...
Tag: hemostatic
Axio Biosolutions, a MedTech company, announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from ...
